Jenthera Therapeutics Inc.
- Biotech or pharma, therapeutic R&D
Jenthera Therapeutics is a preclinical gene editing company revolutionizing in vivo editing through the direct delivery of the CRISPR enzyme without any lipids, viruses or derivatives. The approach features a low cost, simple and high-yield production and unprecedented precision insertional capabilities, allowing to produce highly tailored gene editing complexes for a large spectrum of diseases.